Tilman M. Hackeng, PhD

Chief Scientific Officer
Coagulation Profile, Maastricht, The Netherlands

Presentation(s):

• OC 23.3 - Recurrent venous-thromboembolism: association with thrombin generation and D-Dimer

  Sunday, July 10, 2022
  3:15 PM – 3:30 PM

• PB0097 - Serial thrombin generation, while on LMWH prophylaxis in critically ill COVID-19 patients from the prospective MaastrICCht cohort.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0165 - Protein S Gla detects and attenuates early vascular calcification

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• MC 12.1 - Anticoagulant Regulation of Coagulation Onset

  Monday, July 11, 2022
  1:15 PM – 2:00 PM

• PB0717 - In vitro Rescue of a Nonsense Mutation Responsible for Severe Coagulation Factor V Deficiency Using Ribosome Readthrough Agents

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• OC 51.5 - Effects of gender and hormonal status on thrombin generation in a large population-based cohort of twins and their family members

  Tuesday, July 12, 2022
  11:45 AM – 12:00 PM

• OC 55.4 - Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor by post-translational modification of functional arginine residues.

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM

• PB1252 - Role of matrix Gla protein in vascular calcification: hard chemistry for soft vessels

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1303 - Generation of iPSC-derived vascular cells deficient in tissue factor pathway inhibitor

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM